Latest News
IMMUcan has completed patient enrolment
We are thrilled to announce that as of October 30th, we have successfully completed the prospective recruitment for the EORTC [...]
What does personalised medicine mean in practice?
The example of the IMMUcan project European initiatives (Europe’s Beating Cancer Plan, European Health Data Space), conferences and seminars are now [...]
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
EORTC is very proud to inform you that seven IMMUcan abstracts have been selected for the ESMO Immuno-Oncology (ESMO-IO) Congress [...]
Marking Colorectal and Renal Cancer Awareness Month
March marked an important month in the campaign to raise awareness about different types of cancer – it was both [...]
The IMMUcan CIMT eTalk is now available to view
On 10-12 May 2021, the IMMUcan consortium presented an eTalk at the Association for Cancer Immunotherapy (CIMT) annual meeting. The [...]
An Interview with Daniel Schulz on the AACR 2021 IMMUcan Poster
This year, the American Association for Cancer Research (AACR) Annual Meeting 2021 is taking place over two weeks, starting on 10-15 April [...]